Rare diseases
Investigational molecules
Locations
Back to Sweden335 clinical trials in Uppsala, Sweden across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma
SwedenStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
SwedenStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
SwedenStudy on the Safety and Effects of RBD1016 Injection for Patients with Chronic Hepatitis B on Nucleoside Analogues Treatment
SwedenContinued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies
SwedenLong-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients
SwedenStudy on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension
SwedenStudy on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight
SwedenStudy on Dexamethasone Film for Patients with Acute Allergic Reactions
SwedenStudy of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease
SwedenStudy of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy
SwedenStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
SwedenThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic breast cancer and prostate cancer treatments, including targeted therapies and novel drug combinations.
Particular emphasis on HER2-positive breast cancer imaging and treatment optimization.
Research initiatives targeting obesity management and metabolic health, with studies evaluating new therapeutic approaches for weight management in both adults and adolescents.
Focus on innovative drug combinations and long-term effectiveness studies.
Comprehensive research on heart failure prevention and chronic kidney disease management, investigating new therapeutic combinations.
Emphasis on combination therapies and preventive approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
